Achieve Life Sciences (ACHV) Other Working Capital Changes (2010 - 2026)

Achieve Life Sciences (ACHV) has 17 years of Other Working Capital Changes data on file, last reported at -$68000.0 in Q1 2026.

• Quarterly Other Working Capital Changes rose 20.0% year-over-year to -$68000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $210000.0 (down 72.8% YoY) and the FY2025 annual result came in at $193000.0, down 74.77% from the prior year.
• Other Working Capital Changes retreated to -$68000.0 in Q1 2026, from $329000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $1.6 million in Q3 2024 to a low of -$886000.0 in Q1 2023.
• A 5-year average of $37941.2 and a median of -$68000.0 in 2026 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2023 — Other Working Capital Changes slumped 8960.0% — and 2025, when it soared 142.51%.
• Tracing ACHV's Other Working Capital Changes over 5 years: stood at -$325000.0 in 2022, then slumped by 71.69% to -$558000.0 in 2023, then plunged by 38.71% to -$774000.0 in 2024, then soared by 142.51% to $329000.0 in 2025, then sank by 120.67% to -$68000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$68000.0 (Q1 2026), $329000.0 (Q4 2025), and $456000.0 (Q3 2025), per Business Quant data.